drugset / Trial / NCT00002973
Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma
Phase 2
Completed
34 enrolled
University of Wisconsin, Madison
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature. Combining hyperthermia with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of melphalan and whole-body hyperthermia in treating patients with advanced melanoma.
Timeline
- Start
- 1995-12
- Primary completion
- 2000-05
- Completion
- 2000-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melphalan | Small molecule | — | — |